NextPoint Therapeutics
PrivateLast Round
Early Stage
VC
Jul 30, 2026
Total Funding Raised
$196M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NextPoint Therapeutics is a biotechnology company developing precision immuno-oncology therapeutics that target the B7-H7/HHLA2 immune checkpoint axis to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NextPoint Therapeutics Comparables
Compare NextPoint Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harbour BioMed | 78% | |
| BeOne Medicines | 76% | |
| Hummingbird Bioscience | 71% | |
NextPoint Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Jul 30, 2026 | ||||
| Series B Extension | Feb 14, 2024 | ||||
| Series B | Jan 10, 2023 | ||||
| Series A | Aug 13, 2020 |
Key People
Founding team and executive leadership
NextPoint Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | VC Round |
| Sixty Degree Capital | Series B Extension, Series B |
| Binney Street Capital | Series A, VC Round, Series B Extension, Series B |
| MPM BioImpact | Series B, Series A, Series B Extension |
| Catalio Capital Management | Series B, Series B Extension |
| Invus Opportunities | Series B Extension, Series B |
| Arkin Bio Capital | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
$34M raised in early stage VC round.
- Jul 26, 2026
Monthly visitors grew 92% MoM.
NextPoint Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NextPoint Therapeutics's valuation, stock price, and market status.